SVB Leerink reissued their outperform rating on shares of Compugen ( NASDAQ:CGEN – Get Rating ) in a research note released on Tuesday, PriceTargets.com reports. SVB Leerink also issued estimates for Compugen's Q1 2023 earnings at ($0.10) EPS, Q2 2023 earnings at ($0.12) EPS, Q3 2023 earnings at ($0.12) EPS, Q4 2023 earnings at $0.16 EPS, FY2023 earnings at ($0.18) EPS, Q1 2024 earnings at ($0.08) EPS, Q2 2024 earnings at ($0.08) EPS, Q3 2024 earnings at ($0.08) EPS, Q4 2024 earnings at ($0.

https://www.dailypolitical.com/2023/03/03/compugens-cgen-outperform-rating-reaffirmed-at-svb-leerink.html

#dailypolitical